BioStock Analytics - Biostock

CONSENSUS ANALYSIS

Consensus Analysis | Coloplast | 2026-09-01

Consensus Analysis | Zealand Pharma | 2026-08-25

Consensus Analysis | Genmab | 2026-08-21

Consensus Analysis | Novo Nordisk | 2026-08-18

Consensus Analysis | SOBI | 13 August 2026

Consensus Analysis | Getinge | 11 August 2026

Consensus Analysis | Astra Zeneca | 6 August 2026

Consensus Analysis | Novo Nordisk | 19 May 2026

WEEKLY: The Nordic Pulse

BioArctic’s home-run, a third win for Astra’s Tezspire and a path to phase III for Lytix – the Nordic Pulse | 2026:35

AstraZeneca fires three barrels, Implantica enters the US – the Nordic Pulse | 2026:34

Demant raises the bar, XVIVO clears hearts and Zealand cashes in – the Nordic Pulse | 2026:33

BioStock Analytics

We deliver accessible sector news, in-depth company insights alongside trusted data and industry-wide market intelligence.

BioVal – rNPV analyses

BioVal™ analysis: Alzinova’ ALZ-101 valued at SEK 7.1B

BioVal™ analysis: Elicera Therapeutics’ ELC-301 valued at SEK 631M

QUARTERLY: The State of Nordic Biopharma

State of Nordic Biopharma | Q2 2026

State of Nordic Biopharma | Q1 2026

WEEKLY: The Nordic Pulse (cont.)

Novo raises outlook, BioInvent breaks through, Nordics tread water – the Nordic Pulse | 2026:32

Novo misses, AstraZeneca holds steady, Alvotech clears FDA – the Nordic Pulse | 2026:31

Novo sues Lilly, Alligator collapses, Lundbeck completes Phase III – the Nordic Pulse | 2026:30

Leqembi under the skin, Wegovy wins Europe, Sobi lifts guidance – the Nordic Pulse | 2026:29

AstraZeneca drags the index, Ascelia contests the FDA and board drama at BICO – the Nordic Pulse | 2026:28

Hansa closes, AlzeCure soars, Ascelia falters – the Nordic Pulse | 2026:27

BioArctic lands Lilly, Sobi takes a late hit – the Nordic Pulse | 2026:26

Alvotech cashes up, SynAct narrowly misses – the Nordic Pulse | 2026:25

Lilly calls on AlzeCure, Novo Nordisk pops a pill – the Nordic Pulse | 2026:24

Lundbeck breaks through, Sectra breaks records – The Nordic Pulse | 2026:23

Hansa shines, Elekta stumbles, biotech bounces – the Nordic Pulse | 2026:22

Deals, Data and a Dragon Market Debut – the Nordic Pulse | 2026:21